PE Ratio
N/A
Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1D | 1M | 3M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| PE Ratio | - | – | – | – | – | – | – | – | |
| Price | $43.65 | +1.3% | -23.7% | -51.2% | -34.3% | +12.0% | +55.6% | -38.6% | |
| TTM Revenue | $450.82M | -32.7% | – | -32.7% | – | -45.6% | +87.3% | +226.0% | |
| TTM EPS | -$5.10 | -127.3% | – | -127.3% | – | -7485.1% | -164.9% | -276.2% | |
| 122.65 | +1.3% | -23.4% | +352.1% | +664.2% | +980.6% | +1005.0% | +575.8% | ||
| 13.69 | +1.3% | -23.4% | -27.4% | +63.8% | +114.6% | +9.4% | -74.5% | ||
| $6.38B | +1.2% | -22.9% | -48.6% | -28.3% | +25.0% | +113.3% | -9.9% | ||
| -9.37 | -1.2% | +22.9% | +84.8% | -134.3% | -122.5% | +39.7% | +81.4% | ||
| Market Cap | $6B | +1.3% | -23.4% | -51.1% | -32.4% | +16.7% | +104.9% | -16.8% |
Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1M | N/A | N/A | N/A |
| 3M | N/A | N/A | N/A |
| 6M | N/A | N/A | N/A |
| 1Y | 47.46 | N/A | |
| 3Y | 47.46 | N/A | |
| 5Y | 47.46 | N/A | |
| All | 424.45 | N/A |
Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1M | N/A | N/A | N/A |
| 3M | N/A | N/A | N/A |
| 6M | N/A | N/A | N/A |
| 1Y | 35.76 | N/A | |
| 3Y | 35.76 | N/A | |
| 5Y | 35.76 | N/A | |
| All | 35.76 | N/A |
History
| Date | Value | Change |
|---|---|---|
| 43.16 | -63.1% |
| Date | Value | Change |
|---|---|---|
| 117.09 | - |
FAQ
- What is ARWR PE ratio 1-year high?
- ARWR PE ratio reached a 1-year high of 47.46 on February 2, 2026
- What is ARWR PE ratio 1-year low?
- ARWR PE ratio reached a 1-year low of 35.76 on March 12, 2026
Formula
Data Sources & References
- ARWR Official Website arrowheadpharma.com
- ARWR Profile on Yahoo Finance finance.yahoo.com/quote/ARWR
- ARWR Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/arwr
